دورية أكاديمية

All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration†.

التفاصيل البيبلوغرافية
العنوان: All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration†.
المؤلفون: Lewden, Charlotte, Bouteloup, Vincent, De Wit, Stéphane, Sabin, Caroline, Mocroft, Amanda, Wasmuth, Jan Christian, van Sighem, Ard, Kirk, Ole, Obel, Niels, Panos, George, Ghosn, Jade, Dabis, François, Mary-Krause, Murielle, Leport, Catherine, Perez-Hoyos, Santiago, Sobrino-Vegas, Paz, Stephan, Christoph, Castagna, Antonella, Antinori, Andrea, d'Arminio Monforte, Antonella
المصدر: International Journal of Epidemiology; Apr2012, Vol. 41 Issue 2, p433-445, 13p
مصطلحات موضوعية: HIV-positive youth, MORTALITY of AIDS patients, CD4 antigen, COHORT analysis, DATA analysis
مصطلحات جغرافية: EUROPE
مستخلص: Background Using data from a large European collaborative study, we aimed to identify the circumstances in which treated HIV-infected individuals will experience similar mortality rates to those of the general population.Methods Adults were eligible if they initiated combination anti-retroviral treatment (cART) between 1998 and 2008 and had one prior CD4 measurement within 6 months. Standardized mortality ratios (SMRs) and excess mortality rates compared with the general population were estimated using Poisson regression. Periods of follow-up were classified according to the current CD4 count.Results Of the 80 642 individuals, 70% were men, 16% were injecting drug users (IDUs), the median age was 37 years, median CD4 count 225/mm3 at cART initiation and median follow-up was 3.5 years. The overall mortality rate was 1.2/100 person-years (PY) (men: 1.3, women: 0.9), 4.2 times as high as that in the general population (SMR for men: 3.8, for women: 7.4). Among 35 316 individuals with a CD4 count ≥500/mm3, the mortality rate was 0.37/100 PY (SMR 1.5); mortality rates were similar to those of the general population in non-IDU men [SMR 0.9, 95% confidence interval (95% CI) 0.7–1.3] and, after 3 years, in women (SMR 1.1, 95% CI 0.7–1.7). Mortality rates in IDUs remained elevated, though a trend to decrease with longer durations with high CD4 count was seen. A prior AIDS diagnosis was associated with higher mortality.Conclusions Mortality patterns in most non-IDU HIV-infected individuals with high CD4 counts on cART are similar to those in the general population. The persistent role of a prior AIDS diagnosis underlines the importance of early diagnosis of HIV infection. [ABSTRACT FROM AUTHOR]
Copyright of International Journal of Epidemiology is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index